Quick Answer
Ascendis Pharma A/S reported Total Assets of $1.30 billion for fiscal year 2025.
Ascendis Pharma A/S Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.30B | +10.4% |
| 2024 | $1.18B | +42.9% |
| 2023 | $825.59M | -24.2% |
| 2022 | $1.09B | +0.4% |
| 2021 | $1.08B | +10.7% |
| 2020 | $979.79M | +44.8% |
| 2019 | $676.73M | +112.2% |
| 2018 | $318.97M | +51.2% |
| 2017 | $210.98M | +11.0% |
| 2016 | $190.07M | — |
- Ascendis Pharma A/S showed an increase of +10.4% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, Ascendis Pharma A/S’s total assets has grown by 585.3% (from $190.07 million to $1.30 billion).
- The most recent figure is from Ascendis Pharma A/S’s fiscal year 2025 report (Form 20-F), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: